|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 15.193,00 GBX | +0,22% |
|
+9,16% | +9,93% |
| 08:12 | Jane Buus Laursen wordt CCDO bij Camurus | FW |
| 16/02 | ASTRAZENECA : Deutsche Bank is niet overtuigd | ZD |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet (Y-1) | Nettomarge (Y-1) | Ebit-marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
|---|---|---|---|---|---|---|---|
 | 54,07 mld. | 13,01% | 31,31% | 32,11% | 12,51% | 1.47x | |
| 65,18 mld. | 31,67% | 41,84% | 103,86% | 22,92% | 0.95x | |
| 94,19 mld. | 28,46% | 32,23% | 34,62% | 14,26% | 0.73x | |
| 56,33 mld. | 7,59% | 41,43% | 263,08% | 13,34% | 2.56x | |
| 77,58 mld. | 20,94% | 35,49% | 47,65% | 15,43% | 0.66x | |
| 56,67 mld. | 24,64% | 38,62% | 38,4% | 16,33% | 1.02x | |
| 64,17 mld. | 26,68% | 36,46% | 46,35% | 17,38% | 0.86x | |
| 48,59 mld. | 33,14% | 41,3% | 60,7% | 20,31% | 0.69x | |
| 36,75 mld. | 20,98% | 44,09% | 162,88% | 12,98% | 2.13x | |
| 28,75 mld. | 1,67% | 29,63% | 27,6% | 9,57% | 1.48x | |
| 63,63 mld. | 12,62% | 34,24% | 19,99% | 8,05% | 1.52x | |
| 12 mld. | 32,94% | 43,85% | 27,07% | 16,41% | -1.18x | |
| 48,19 mld. | 14,64% | 30,37% | 72,08% | 7,72% | 1.83x | |
| 39,28 mld. | 8,21% | 29,16% | 48,09% | 10,97% | 1.22x | |
| 42,53 mld. | 13,98% | 27,61% | 11,75% | 4,43% | 0.68x | |
| 7,45 mld. | 33,09% | 46,3% | 22% | 18,71% | -1.74x | |
| 30,6 mld. | 2,36% | 7,48% | 1,5% | 1,19% | 3.6x | |
| 3,83 mld. | 22,64% | 26,77% | 14,73% | 13,49% | -2.98x | |
| 48,25 mld. | -5,48% | 11,66% | 15,32% | -2,25% | 3.2x | |
| Gemiddelde | 46,21 mld. | 18,09% | 33,15% | 55,25% | 12,3% | 0,98x | |
| Gewogen gemiddelde per kap. | 58,57 mld. | 21,82% | 36,44% | 75% | 15,33% | 1,07x |
- Beurs
- Aandelen
- Koers AZN
- Sector AstraZeneca PLC
- Financiële vergelijkingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
